Jacqueline Benson,

Vice President, Scientific Innovation, Immunology

Jackie is Vice President, Scientific Innovation, Immunology at Johnson & Johnson Innovation, California.  In this role, she is responsible for creating and implementing an external innovation plan focused on developing an industry-leading portfolio of Immunology investment opportunities on the West Coast.  
Jackie continues to serve as Estrela Venture Leader, Janssen Incubator, advancing innovative treatments for systemic lupus erythematosus (SLE). Since Estrela launched in 2013, Jackie has led the Estrela Venture to a number of key milestones, including the declaration of two new molecular entities, one of which recently achieved first patient dosed in SLE patients. Jackie joined the Janssen Pharmaceutical Companies of Johnson & Johnson as a Senior Research Scientist in 2001, playing an instrumental role in the research and discovery of several flagship programs, including STELARA® (ustekinumab) and guselkumab.  
Jacky received her B.S. in Biology from The Ohio State University, followed by her Ph.D. in Immunology from the College of Medicine at The Ohio State University, and was awarded a National Multiple Sclerosis Society postdoctoral fellowship at Stanford University School of Medicine.

Jacqueline Benson
Jacqueline Benson